Product Information
PROCHLORPERAZINE 10 MG TAB is a generic product labeled by Major Pharmaceuticals, priced at $0.1621 per EA under NDC 00904738206. Its NADAC has been published 137 times since Feb 21, 2024.
FDA first approved this application on Jun 13, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904738206
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PROCHLORPERAZINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA216202FDA Approved
6/13/2022
TE Code
AB
On Market Since
8/1/2022
Pharmacological Classes
Price Statistics
The NADAC for PROCHLORPERAZINE 10 MG TAB has been published 137 times since Feb 21, 2024, and over the history we have for it it has declined 48.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1621 per EA |
|---|---|
| All-time high | $0.3116 (Mar 13, 2024) |
| All-time low | $0.1493 (Nov 20, 2024) |
| 52-week high | $0.2036 |
| 52-week low | $0.1621 |
| Median price | $0.1990 |
| Average price | $0.2092 |
| Largest weekly change | -40.9% (Nov 20, 2024) |
| Weeks tracked | 137 |
| Tracking since | Feb 21, 2024 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Prochlorperazine Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROCHLORPERAZINE 10 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for PROCHLORPERAZINE 10 MG TAB, manufactured by Major Pharmaceuticals, is $0.1621 per EA (NDC 00904738206), effective Sep 30, 2026.
How has the price of PROCHLORPERAZINE 10 MG TAB changed over time?
Over the history we have for it, the NADAC for PROCHLORPERAZINE 10 MG TAB has declined 48.0%. It has been tracked across 137 weekly CMS publications since Feb 21, 2024.
What are the highest and lowest recorded NADAC prices for PROCHLORPERAZINE 10 MG TAB?
Since Feb 21, 2024, the NADAC for PROCHLORPERAZINE 10 MG TAB has ranged from a low of $0.1493 (Nov 20, 2024) to a high of $0.3116 (Mar 13, 2024), with a median of $0.1990 per EA.
Are there cheaper alternatives to PROCHLORPERAZINE 10 MG TAB?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PROCHLORPERAZINE 10 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures PROCHLORPERAZINE 10 MG TAB?
PROCHLORPERAZINE 10 MG TAB (NDC 00904738206) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.